StockClub

BMRN

BMRNBioMarin Pharmaceutical Inc.$ --
BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

BMRN

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
766M USD
YoY +2.8%
Operating Income
130M USD
YoY -42.1%
Net Income
106M USD
YoY -43.2%
EPS
0.55$
YoY -43.3%

Revenue

$766.2M
FY2024 Q2$1.4B
$1.4B
Q2
FY2024 Q3$2.1B
$2.1B
Q3
FY2024 Q4$2.9B
$2.9B
Q4
FY2025 Q1$745.1M
$745.1M
Q1
FY2025 Q2$1.6B
$1.6B
Q2
FY2025 Q3$2.3B
$2.3B
Q3
FY2025 Q4$3.2B
$3.2B
Q4
FY2026 Q1$766.2M
$766.2M
Q1
Actual
+$21.1M (+2.8%)

Net Income

$105.5M
FY2024 Q2$195.8M
$195.8M
Q2
FY2024 Q3$301.9M
$301.9M
Q3
FY2024 Q4$426.9M
$426.9M
Q4
FY2025 Q1$185.7M
$185.7M
Q1
FY2025 Q2$426.2M
$426.2M
Q2
FY2025 Q3$395.5M
$395.5M
Q3
FY2025 Q4$348.9M
$348.9M
Q4
FY2026 Q1$105.5M
$105.5M
Q1
Actual
$-80.2M (-43.2%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$1.9B
Est:$1.9B
FY2020BEAT
$1.9B
FY2021BEAT
Actual:$1.8B
Est:$1.8B
FY2021BEAT
$1.8B
FY2022MISS
Actual:$2.1B
Est:$2.1B
FY2022MISS
$2.1B
FY2023MISS
Actual:$2.4B
Est:$2.6B
FY2023MISS
$2.4B
FY2024BEAT
Actual:$2.9B
Est:$2.8B
FY2024BEAT
$2.9B
FY2025BEAT
Actual:$3.2B
Est:$3.2B
FY2025BEAT
$3.2B

Analyst Estimates